Diethyl Ether → Tert-butyl 4-(6-chloropyrazin-2-YL)piperazine-1-carboxylate

HRID 1357577Notes

Reaction equation

HRID 1357577 reaction equation
[N:1]1([C:7]([O:9][C:10]([CH3:13])([CH3:12])[CH3:11])=[O:8])[CH2:6][CH2:5][NH:4][CH2:3][CH2:2]1.[Cl:14][C:15]1[CH:20]=[N:19][CH:18]=[C:17](Cl)[N:16]=1.C([O-])([O-])=O.[K+].[K+].CCOCC>C(#N)C>[Cl:14][C:15]1[N:16]=[C:17]([N:4]2[CH2:5][CH2:6][N:1]([C:7]([O:9][C:10]([CH3:13])([CH3:12])[CH3:11])=[O:8])[CH2:2][CH2:3]2)[CH:18]=[N:19][CH:20]=1

Participants

6

Conditions

Temperature
65 °C

Procedure

A mixture of tert-butyl 1-piperazinecarboxylate (5.07 g, 27.2 mmol), 2,6-dichloropyrazine (3.38 g, 22.7 mmol), and K2CO3 (4.09 g, 30.0 mmol) in acetonitrile (20 mL) was stirred at 65° C. for 12.5 h and for a further 15 h at room temperature. Ether was added and the suspension was filtered. Concentration in vacuo furnished the crude product as an oil that crystallized upon standing. Purification by chromatography on silica gel using ethyl acetate/n-hexane (6:4) as eluent gave 6.1 g (90%) of the title compound as a solid. HRMS m/z calcd for C13H19ClN4O2 (M)+ 298.1197, found 298.1211. Anal. (C13H19ClN4O2) C, H, N.

Workup

  1. filtrationthe suspension was filtered
  2. concentrationConcentration in vacuo
  3. customfurnished the crude product as an oil that
  4. customcrystallized
  5. customPurification by chromatography on silica gel

Sources & evidence

ORD record
ord-817d9d959b4e4745990ca541c4b0c93b
Source dataset
uspto-grants-2003_07
Patent number
US06593330B2

Reaction notes

Loading…